Oregon wants to get out of covering drugs like Aduhelm in Medicaid
WASHINGTON — Oregon is gearing up to ask the Biden administration if its Medicaid program can avoid paying for drugs approved through a fast-track approval pathway — like Biogen’s pricey, controversial new Alzheimer’s drug, Aduhelm.
Oregon announced this month it is planning to formally submit a request to the administration to let its state out of a law that requires Medicaid programs to cover nearly all Food and Drug Administration-approved drugs.
https://www.statnews.com/2021/12/14/oregon-wants-to-get-out-of-covering-drugs-like-aduhelm-in-medicaid
